Related Experiment Video
Updated: Jun 12, 2026

Investigating Intestinal Inflammation in DSS-induced Model of IBD
Published on: February 1, 2012
Inflammatory Bowel Disease: A Stressed "Gut/Feeling".
Yvonne Oligschlaeger1, Tulasi Yadati1, Tom Houben1
1School of Nutrition & Translational Research in Metabolism (NUTRIM), Department of Molecular Genetics, Maastricht University, Universiteitssingel 50, 6229 ER Maastricht, The Netherlands.
Stress significantly impacts inflammatory bowel disease (IBD) by disrupting the gut-brain axis. Managing stress is crucial for IBD remission and preventing disease progression.
Area of Science:
- Gastroenterology
- Neuroscience
- Immunology
Background:
- Inflammatory bowel disease (IBD) is a chronic condition characterized by gut-brain axis dysregulation.
- The gut-brain axis involves complex communication pathways including the nervous system, immune system, and gut microbiota.
- Stress is increasingly recognized as a factor influencing IBD activity and relapse.
Purpose of the Study:
- To review the interplay between the gut microbiota, brain, and chronic gastrointestinal inflammation in IBD.
- To elucidate the specific role of stress in modulating the gut-brain axis in IBD.
- To evaluate the therapeutic potential of stress management strategies for IBD.
Main Methods:
- Literature review focusing on the gut-brain axis in IBD.
- Analysis of studies investigating the impact of stress on intestinal inflammation and permeability.
- Evaluation of research on stress management interventions in IBD patients.
Main Results:
- Stress negatively affects the gut-brain axis, altering intestinal permeability and cytokine profiles.
- These alterations induced by stress can exacerbate IBD relapse risk and disease severity.
- Evidence suggests stress management interventions may offer therapeutic benefits in IBD.
Conclusions:
- The gut-brain-microbiota axis is central to IBD pathogenesis.
- Stress is a significant environmental factor contributing to IBD exacerbations.
- Stress management represents a promising complementary therapeutic approach for IBD management.
Related Concept Videos
Irritable Bowel Syndrome I: Introduction
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Inflammatory Bowel Disease I: Ulcerative Colitis
Inflammatory bowel disease, or IBD, encompasses a group of disorders characterized by chronic inflammation or ulceration of the gastrointestinal tract.
Risk Factors
The exact cause of IBD remains unclear, although it is believed to be due to a mix of genetic, environmental, microbial, and immune factors. Genetic factors are significant in determining susceptibility to IBD, with family history being a critical risk factor. Individuals with a first-degree relative who has IBD are at...
Inflammatory Bowel Disease II: Crohn's Disease
Inflammatory bowel disease, commonly known as IBD, refers to a collection of disorders that lead to persistent inflammation of the gastrointestinal tract. The two types of IBD are ulcerative colitis, which impacts the colon, and Crohn's disease, which can involve any part of the gastrointestinal segment.
Crohn's disease
Crohn's disease is a chronic, systemic inflammatory bowel disease (IBD) that predominantly affects the gastrointestinal tract. It is marked by transmural...
Inflammatory Bowel Disease I: Introduction
Inflammatory Bowel Disease II: Ulcerative Colitis
Irritable Bowel Syndrome

